JP2000514075A - ベンゾ[g]キノリン誘導体 - Google Patents
ベンゾ[g]キノリン誘導体Info
- Publication number
- JP2000514075A JP2000514075A JP10504788A JP50478898A JP2000514075A JP 2000514075 A JP2000514075 A JP 2000514075A JP 10504788 A JP10504788 A JP 10504788A JP 50478898 A JP50478898 A JP 50478898A JP 2000514075 A JP2000514075 A JP 2000514075A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- acid addition
- addition salt
- free base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.式I [式中、 AおよびBは、各々Hであるか、または共に二重結合を形成し、 XはCH2またはCOであり、 Yは、O、S、S=O、NR1[R1はHまたは(C1-4)アルキル]、CH2または O−CH2であり、 Rは、式(a)、(b)、(c)、(d)、(e)、(f)、(g)、(h)または(i) 〔式中、 R1は上記で定義した通りであり、R2はHまたはトリフルオロメチルであり、Z1 はO、SまたはNHであり、Z2はCHまたはNである〕 で示され、 ただし、XはCH2であり、YはSであり、Rは式(a)(式中、フリー結合は窒 素に隣接しており、R2はHである)で示されるならば、AおよびBはHでない ] で示される、遊離塩基または酸付加塩形の化合物。 2.AおよびBおよびXは請求項1で定義した通りであり、YはO、S、NR1[ R1はHまたは(C1-4)アルキル]、CH2またはO−CH2であり、Rは式(a)、( b)、(c)、(d)または(g)(式中、R1は上記で定義した通りであり、R2はH である)または式(e)または(f)(式中、R1はHであり、Z1はOまたはSであ り、Z2はCHである)で示される、請求項1に定義した遊離塩基または酸付加 塩形の式Iで示される化合物。 3.[3R,4aR,10aR]−1−メチル-3β−{4−メチル−(4H)−1,2, 4−トリアゾ-3-イル}チオメチル-6−ヒドロキシ-1,2,3,4,4aα,5,1 0,10aβ−オクタヒドロベンゾ[g]キノリン、[4aS,10aR]−1,2,4 aα,5,10,10aβ-ヘキサヒドロ−6−ヒドロキシ-1−メチル-3−(2− ピリジルオキシメチル)−ベンゾ[g]キノリン、[4aS,10aR]−1,2,4a α,5,10,10aβ−ヘキサヒドロ−6−ヒドロキシ-1−メチル−3−(2− イミダゾリルチオメチル)−ベンゾ[g]キノリンおよび[3R,4aR,10aR] −1−メチル−3β−(2−ピリジル−N−オキシド)チオメチル−6−ヒドロキ シ−1,2,3,4,4aα,5,10,10aβ−オクタヒドロベンゾ[g]キノリン から選択した遊離塩基または酸付加塩形の請求項1に記載の化合物。 4.式II [式中、 A、B、X、YおよびRは請求項1で定義した通りであり、R2は(C1-4)アルキ ルである] で示される化合物において、アルコキシ基をヒドロキシ基に変換し、かくして得 られた式Iで示される化合物を遊離塩基または酸付加塩形で回収する段階を含む 、請求項1で定義した式Iで示される化合物またはその塩の製造法。 5.医薬品として使用する遊離塩基または医薬的に許容される酸付加塩形の請求 項1−3のいずれか1つに記載の化合物。 6.緑内障および近視の治療に使用する遊離塩基または医薬的に許容される酸付 加塩形の請求項1−3のいずれか1つに記載の化合物。 7.医薬担体または希釈剤と共に、遊離塩基または医薬的に許容される酸付加塩 形の請求項1−3のいずれか1つに記載の化合物を含む医薬組成物。 8.緑内障および近視の治療の医薬品としての、遊離塩基または医薬的に許容さ れる酸付加塩形の請求項1−3のいずれか1つに記載の化合物の使用。 9.緑内障および近視の治療の医薬品製造における、遊離塩基または医薬的に許 容される酸付加塩形の請求項1−3のいずれか1つに記載の化合物の使用。 10.患者に治療有効量の遊離塩基または医薬的に許容される酸付加塩形の請求 項1−3のいずれか1つに記載の化合物を投与することを含む、治療を必要とす る患者における緑内障および近視の治療法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9614282.3A GB9614282D0 (en) | 1996-07-08 | 1996-07-08 | Organic compounds |
GB9614282.3 | 1996-07-08 | ||
GB9626093.0 | 1996-12-16 | ||
GBGB9626093.0A GB9626093D0 (en) | 1996-12-16 | 1996-12-16 | Organic compounds |
PCT/EP1997/003582 WO1998001444A1 (en) | 1996-07-08 | 1997-07-07 | BENZO[g]QUINOLINE DERIVATIVES |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2000514075A true JP2000514075A (ja) | 2000-10-24 |
JP2000514075A5 JP2000514075A5 (ja) | 2005-03-10 |
JP4216337B2 JP4216337B2 (ja) | 2009-01-28 |
Family
ID=26309658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50478898A Expired - Fee Related JP4216337B2 (ja) | 1996-07-08 | 1997-07-07 | ベンゾ[g]キノリン誘導体 |
Country Status (28)
Country | Link |
---|---|
US (1) | US6057334A (ja) |
EP (1) | EP0912553B1 (ja) |
JP (1) | JP4216337B2 (ja) |
KR (1) | KR100491478B1 (ja) |
CN (1) | CN1125065C (ja) |
AR (1) | AR007814A1 (ja) |
AT (1) | ATE211470T1 (ja) |
AU (1) | AU719119B2 (ja) |
BR (1) | BR9710218A (ja) |
CA (1) | CA2257646C (ja) |
CO (1) | CO4870760A1 (ja) |
CY (1) | CY2322B1 (ja) |
CZ (1) | CZ2799A3 (ja) |
DE (1) | DE69709869T2 (ja) |
DK (1) | DK0912553T3 (ja) |
ES (1) | ES2170402T3 (ja) |
HK (1) | HK1020569A1 (ja) |
ID (1) | ID18896A (ja) |
IL (1) | IL127376A (ja) |
NO (1) | NO319401B1 (ja) |
NZ (1) | NZ333311A (ja) |
PE (1) | PE87998A1 (ja) |
PL (1) | PL330723A1 (ja) |
PT (1) | PT912553E (ja) |
SK (1) | SK399A3 (ja) |
TR (1) | TR199900016T2 (ja) |
TW (1) | TW378209B (ja) |
WO (1) | WO1998001444A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007504198A (ja) * | 2003-09-05 | 2007-03-01 | ノバルティス アクチエンゲゼルシャフト | ベンゾ[g]キノリン誘導体とプロスタグランジン誘導体を含む、組成物 |
JP2010095550A (ja) * | 2002-03-07 | 2010-04-30 | Novartis Ag | キノリン誘導体 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20030240A1 (es) * | 2001-07-09 | 2003-04-16 | Novartis Ag | DERIVADOS DE BENZO [g] QUINOLINA |
SI1757601T1 (sl) * | 2002-03-07 | 2009-12-31 | Novartis Ag | Kinolinski derivati in njihova uporaba pri glavkomu in miopiji |
CN105434439B (zh) * | 2015-11-11 | 2018-07-24 | 温州医科大学 | 一种多巴胺d2受体的部分激动剂在制备抑制近视药物上的应用及其使用方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU88619I2 (fr) * | 1981-10-16 | 1995-07-10 | Sandoz Ag | QUINAGOLIDE, éventuellement sous forme de sel, par exemple du chlorhydrate |
WO1990000896A1 (en) * | 1988-07-22 | 1990-02-08 | Sandoz Ag | USE OF BENZO(g)QUINOLINES IN TREATMENT OF NICOTINE ADDICTION |
GB8829330D0 (en) * | 1988-12-16 | 1989-02-01 | Sandoz Ltd | Improvements in or relating to organic compounds |
US5262422A (en) * | 1991-05-02 | 1993-11-16 | Sandoz Ltd. | Octahydrobenzo[g]quinoline |
DE4114325A1 (de) * | 1991-05-02 | 1992-11-05 | Sandoz Ag | Octahydrobenzo(g)chinolin, seine herstellung und verwendung |
GB9326010D0 (en) * | 1993-12-21 | 1994-02-23 | Sandoz Ltd | Improvements in or relating to organic compounds |
FR2729145A1 (fr) * | 1995-01-06 | 1996-07-12 | Smithkline Beecham Lab | Nouveaux derives d'amine, leur procede de preparation et leur utilisation en tant que medicaments et notamment en tant qu'agents anti-arythmiques |
-
1997
- 1997-06-16 TW TW086108396A patent/TW378209B/zh not_active IP Right Cessation
- 1997-07-07 ES ES97931793T patent/ES2170402T3/es not_active Expired - Lifetime
- 1997-07-07 US US09/214,537 patent/US6057334A/en not_active Expired - Lifetime
- 1997-07-07 AU AU35422/97A patent/AU719119B2/en not_active Ceased
- 1997-07-07 CO CO97037766A patent/CO4870760A1/es unknown
- 1997-07-07 SK SK3-99A patent/SK399A3/sk unknown
- 1997-07-07 AR ARP970103017A patent/AR007814A1/es active IP Right Grant
- 1997-07-07 CN CN97196208A patent/CN1125065C/zh not_active Expired - Fee Related
- 1997-07-07 JP JP50478898A patent/JP4216337B2/ja not_active Expired - Fee Related
- 1997-07-07 PL PL97330723A patent/PL330723A1/xx unknown
- 1997-07-07 ID IDP972340A patent/ID18896A/id unknown
- 1997-07-07 PT PT97931793T patent/PT912553E/pt unknown
- 1997-07-07 DK DK97931793T patent/DK0912553T3/da active
- 1997-07-07 DE DE69709869T patent/DE69709869T2/de not_active Expired - Lifetime
- 1997-07-07 WO PCT/EP1997/003582 patent/WO1998001444A1/en active IP Right Grant
- 1997-07-07 BR BR9710218A patent/BR9710218A/pt not_active IP Right Cessation
- 1997-07-07 EP EP97931793A patent/EP0912553B1/en not_active Expired - Lifetime
- 1997-07-07 PE PE1997000585A patent/PE87998A1/es not_active Application Discontinuation
- 1997-07-07 KR KR10-1999-7000016A patent/KR100491478B1/ko not_active IP Right Cessation
- 1997-07-07 IL IL12737697A patent/IL127376A/xx not_active IP Right Cessation
- 1997-07-07 NZ NZ333311A patent/NZ333311A/en not_active IP Right Cessation
- 1997-07-07 AT AT97931793T patent/ATE211470T1/de active
- 1997-07-07 CZ CZ9927A patent/CZ2799A3/cs unknown
- 1997-07-07 TR TR1999/00016T patent/TR199900016T2/xx unknown
- 1997-07-07 CA CA002257646A patent/CA2257646C/en not_active Expired - Fee Related
-
1999
- 1999-01-05 NO NO19990035A patent/NO319401B1/no not_active IP Right Cessation
- 1999-11-02 HK HK99104973A patent/HK1020569A1/xx not_active IP Right Cessation
-
2003
- 2003-04-30 CY CY0300034A patent/CY2322B1/xx unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010095550A (ja) * | 2002-03-07 | 2010-04-30 | Novartis Ag | キノリン誘導体 |
JP2007504198A (ja) * | 2003-09-05 | 2007-03-01 | ノバルティス アクチエンゲゼルシャフト | ベンゾ[g]キノリン誘導体とプロスタグランジン誘導体を含む、組成物 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20030046395A (ko) | 인돌 유도체를 사용하여 안압을 감소시키는 방법 | |
KR100278379B1 (ko) | 삼중고리 아미노알킬카르복스아미드; 신규한 도파민 d₃수용체 서브타입 특이적 리간드 | |
JP2010024243A (ja) | 緑内障および近視を処置するためのベンゾ[g]キノリン誘導体 | |
JP2010095550A (ja) | キノリン誘導体 | |
JP2000512644A (ja) | 5―ht―2c受容体アンタゴニストとして有用なインドリン誘導体 | |
JP2000514075A (ja) | ベンゾ[g]キノリン誘導体 | |
EP0894799B1 (en) | Indolomorphinane derivatives and remedies/preventives for cerebral disorders | |
JP4021481B2 (ja) | 抗ガストリン活性を持つ芳香族酸ジアミド類、その製造法および医薬用途 | |
AU2002328856A1 (en) | Benzo (G) quinoline derivatives for treating glaucoma and myopia | |
JP2000504730A (ja) | 製薬学的活性物質及び使用方法 | |
JPH10513460A (ja) | 血管収縮性の置換2,3−ジヒドロ−1,4−ジオキシノピリジン | |
JP2002529470A (ja) | 縮合ピリダジノン化合物 | |
JP4708567B2 (ja) | N−複素環化合物のカルボン酸およびカルボン酸アイソスター | |
EP1757601A1 (en) | Quinoline derivatives and their use in glaucoma and myopia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040706 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040706 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080219 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080519 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080630 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080619 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080728 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080722 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080901 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080819 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20081028 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20081106 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111114 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111114 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121114 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121114 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131114 Year of fee payment: 5 |
|
LAPS | Cancellation because of no payment of annual fees |